Azithromycin for the prevention of rehospitalisation and death among Kenyan children being discharged from hospital: a double-blind, placebo-controlled, randomised controlled trial

• Main Authors: Patricia B Pavlinac, PhD (Author), Benson O Singa, MBChB (Author), Kirkby D Tickell, MBBS (Author), Rebecca L Brander, PhD (Author), Christine J McGrath, PhD (Author), Mary Amondi, BA (Author), Joyce Otieno, DIP (Author), Elizabeth Akinyi, BSc (Author), Doreen Rwigi, BSc (Author), Joseph D Carreon, MS (Author), Stephanie N Tornberg-Belanger, MPH (Author), Ruth Nduati, MMed (Author), Joseph B Babigumira, PhD (Author), Liru Meshak, MBChB (Author), George Bogonko, MMed (Author), Samuel Kariuki, PhD (Author), Barbra A Richardson, PhD (Author), Grace C John-Stewart, MD (Author), Judd L Walson, MD (Author)
• Format: Book
• Published: Elsevier, 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Mass drug administration of azithromycin to children in sub-Saharan Africa has been shown to improve survival in high-mortality settings. The period after hospital discharge is a time of elevated risk unaddressed by current interventions and might provide an opportunity for targ...